Cinemark (CNK)
NYSE:CNK
Top Page
Cinemark Holdings
(NYSE:CNK)
Select Model
Select Model
Rating:61Neutral
Price Target:
$28.00
▲(1.19% Upside)
Action:ReiteratedDate:02/19/26
CNK scores as moderately attractive, led by improving operating fundamentals and strong cash generation but held back by elevated leverage and signs of 2025 margin compression. Technicals are mildly supportive (positive MACD and price above short-term averages), while valuation is only fair given a ~24.7 P/E and modest dividend yield. The latest earnings call adds support via upbeat 2026 guidance and multiple growth levers, tempered by cost and slate/capacity risks.
Positive Factors
Cash Generation
Strong and improving operating cash flow (≈$396M in 2025) and a ~42% rebound in free cash flow provide durable internal funding for debt reduction, targeted CapEx and shareholder returns. Reliable FCF underpins strategic flexibility and long-term deleveraging even if growth moderates.
Negative Factors
Elevated Leverage
Material leverage (~2.8x D/E) leaves the company more sensitive to box-office volatility or cost shocks, constraining strategic flexibility. Even with progress, high leverage limits capacity for sizable M&A, large buybacks, or rapid reinvestment without sustained FCF or slower debt paydown.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash Generation
Strong and improving operating cash flow (≈$396M in 2025) and a ~42% rebound in free cash flow provide durable internal funding for debt reduction, targeted CapEx and shareholder returns. Reliable FCF underpins strategic flexibility and long-term deleveraging even if growth moderates.
Read all positive factors
Cinemark Holdings (CNK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.25B
Dividend Yield1.45%
Average Volume (3M)2.45M
Price to Earnings (P/E)19.4
Beta (1Y)0.44
Revenue Growth9.70%
EPS Growth-31.62%
CountryUS
Employees9,252
SectorCommunication Services
Sector Strength97
IndustryEntertainment
Share Statistics
EPS (TTM)0.16
Shares Outstanding115,526,240
10 Day Avg. Volume1,830,611
30 Day Avg. Volume2,449,437
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)6.63
Price to Sales (P/S)0.86
P/FCF Ratio15.16
Enterprise Value/Market Cap2.08
Enterprise Value/Revenue2.16
Enterprise Value/Gross Profit5.32
Enterprise Value/Ebitda13.20
Forecast
1Y Price Target
$31.30Price Target Upside13.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)2.05
Revenue Forecast (FY)$3.42B
Cinemark Holdings Business Overview & Revenue Model
Company Description
Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was found...
How the Company Makes Money
Cinemark generates revenue primarily through ticket sales and concessions. The bulk of its earnings comes from admissions, as customers pay for tickets to view films in its theaters. Additionally, the company profits from the sale of food and beve...
Cinemark Holdings Key Performance Indicators (KPIs)
Any
Total Attendance
Measures the total number of patrons visiting theaters, indicating overall popularity and demand for movie experiences.
Measures the total number of patrons visiting theaters, indicating overall popularity and demand for movie experiences.
Data provided by:
The Fly
The FlyCinemark Holdings Earnings Call Summary
Earnings Call Date:Feb 18, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 01, 2026
Earnings Call Sentiment Positive
Overall the call was constructive and largely positive: management highlighted record 2025 revenue, strong adjusted EBITDA ($578M) and margin (18.6%), multi-year cash generation, significant debt paydown, large reinvestment in CapEx, and meaningful gains in concessions, loyalty and alternative content. The company is ramping CapEx to $250M in 2026 and sees multiple organic growth levers. Key risks discussed include a softer-than-expected 2025 slate (pressure on attendance), international attendance variability, rising operating costs, potential capacity constraints in a busier 2026 slate, and uncertainty around theatrical windowing and industry consolidation. On balance, the company portrayed strong financial and operational momentum while acknowledging manageable industry and cost headwinds.Positive Updates
Record Revenue and Strong Adjusted EBITDA
Worldwide revenue reached $3,100,000,000 (post-pandemic high) in FY2025, producing $578,000,000 of adjusted EBITDA and an 18.6% adjusted EBITDA margin.
Negative Updates
Softer-Than-Expected Film Slate and Attendance Pressure in 2025
Management noted 2025 underperformed relative to expectations due to a mixed slate, absence of a >$1,000,000,000 mega-blockbuster and no major summer animated hit; attendance was cited as a headwind to 2025 margins.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Revenue and Strong Adjusted EBITDA
Worldwide revenue reached $3,100,000,000 (post-pandemic high) in FY2025, producing $578,000,000 of adjusted EBITDA and an 18.6% adjusted EBITDA margin.
Read all positive updates
Company Guidance
Management guided 2026 to benefit from a robust slate and higher release volume (approaching pre‑pandemic levels), expecting stronger box office and attendance to drive margin expansion versus 2025’s $3.1B revenue and $578M adjusted EBITDA (18.6% margin); they forecast modest full‑year average ticket price growth, moderate year‑over‑year concession per‑cap gains (domestic per‑caps were +5% in 2025, driven roughly +3 pts pricing, +1 pt incidence, +1 pt mix), and operational leverage from higher attendance, while ramping CapEx to $250M in 2026 (with roughly $50–60M typically allocated to international) to fund new builds (El Paso opened 2025; Greenville slated 2026; Omaha 2027), premium expansion (premium formats ~15% of box office; ~10% of domestic sites have two XDs; U.S. recliner penetration ~72%), continued Movie Club growth (>50% vs 2019), and further upside from alternative content (now >10% of box office and >2x 2019 proceeds).Cinemark Holdings Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
45
Neutral
Cash Flow
68
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.12B | 3.05B | 3.07B | 2.45B | 1.51B |
| Gross Profit | 577.90M | 1.96B | 570.60M | 1.58B | 997.60M |
| EBITDA | 543.70M | 616.30M | 603.90M | 151.70M | -300.00K |
| Net Income | 138.20M | 309.70M | 188.20M | -271.20M | -422.80M |
Balance Sheet | |||||
| Total Assets | 4.43B | 5.07B | 4.84B | 4.82B | 5.23B |
| Cash, Cash Equivalents and Short-Term Investments | 344.30M | 1.06B | 849.10M | 674.50M | 707.30M |
| Total Debt | 3.78B | 3.46B | 3.55B | 3.78B | 3.95B |
| Total Liabilities | 4.02B | 4.46B | 4.52B | 4.70B | 4.90B |
| Stockholders Equity | 405.20M | 594.40M | 309.80M | 110.20M | 322.90M |
Cash Flow | |||||
| Free Cash Flow | 177.20M | 315.20M | 294.80M | 25.30M | 70.70M |
| Operating Cash Flow | 396.10M | 466.00M | 444.30M | 136.00M | 166.20M |
| Investing Cash Flow | -209.20M | -146.90M | -131.80M | -96.30M | -89.30M |
| Financing Cash Flow | -913.10M | -103.10M | -125.40M | -52.20M | -19.90M |
Cinemark Holdings Technical Analysis
Positive
27.67
Price Trends
25.72
Positive
25.63
Positive
26.70
Positive
Market Momentum
0.40
Negative
58.63
Neutral
88.57
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CNK, the sentiment is Positive. The current price of 27.67 is above the 20-day moving average (MA) of 27.18, above the 50-day MA of 25.72, and above the 200-day MA of 26.70, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 58.63 is Neutral, neither overbought nor oversold. The STOCH value of 88.57 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CNK.
Cinemark Holdings Risk Analysis
Cinemark Holdings disclosed 26 risk factors in its most recent earnings report. Cinemark Holdings reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Cinemark Holdings Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $2.04B | 56.84 | 10.67% | ― | 9.30% | 67.19% | |
65 Neutral | $2.69B | 6.89 | -618.85% | ― | 0.68% | -80.73% | |
61 Neutral | $3.25B | 19.44 | 25.84% | 1.45% | 9.70% | -31.62% | |
61 Neutral | $3.85B | 13.10 | 1.51% | ― | 24.54% | -119.75% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
51 Neutral | $2.72B | -14.33 | 20.86% | ― | 97.19% | -21.46% | |
44 Neutral | $538.59M | -1.27 | 35.45% | ― | 9.74% | 12.29% |
* Communication Services Sector Average
CNK
Cinemark Holdings
28.11
2.68
10.52%
IMAX
IMAX
37.75
10.72
39.66%
AMC
AMC Entertainment
0.97
-2.00
-67.40%
SPHR
Sphere Entertainment
108.33
74.55
220.69%
LION
Lionsgate Studios
9.39
1.73
22.58%
MSGE
Madison Square Garden Entertainment Corp.
56.88
22.99
67.84%
Cinemark Holdings Corporate Events
Business Operations and StrategyFinancial Disclosures
Cinemark Posts Record 2025 Revenue and Market Share Gains
Positive
Feb 18, 2026
On February 18, 2026, Cinemark Holdings reported its fourth-quarter and full-year 2025 results, highlighting its highest post-pandemic revenue of $3.1 billion for the year and strong operating performance despite a softer film slate. The company e...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.